Home › Trial NCT01151670
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors
- Trial IDNCT01151670
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorWake Forest University Health Sciences
- Enrollment18
- Start date2010-08
- ConditionsBrain Neoplasms, Malignant · Brain Neoplasms, Benign · Malignant Meningioma · Glioblastoma Multiforme · Anaplastic Astrocytoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.